Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | tyrosyl-DNA phosphodiesterase 2 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Brugia malayi | Endonuclease/Exonuclease/phosphatase family protein | Get druggable targets OG5_131766 | All targets in OG5_131766 |
Echinococcus granulosus | traf and tnf receptor associated protein | Get druggable targets OG5_131766 | All targets in OG5_131766 |
Toxoplasma gondii | endonuclease/exonuclease/phosphatase family protein | Get druggable targets OG5_131766 | All targets in OG5_131766 |
Echinococcus multilocularis | traf and tnf receptor associated protein | Get druggable targets OG5_131766 | All targets in OG5_131766 |
Neospora caninum | endonuclease/exonuclease/phosphatase domain- containing protein, putative | Get druggable targets OG5_131766 | All targets in OG5_131766 |
Loa Loa (eye worm) | endonuclease/Exonuclease/phosphatase | Get druggable targets OG5_131766 | All targets in OG5_131766 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Trypanosoma brucei | KREX1 | tyrosyl-DNA phosphodiesterase 2 | 362 aa | 321 aa | 20.9 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | Eukaryotic initiation factor 4A-1 | 0.0593 | 0.5 | 0.5 |
Echinococcus granulosus | eukaryotic initiation factor 4A | 0.0593 | 0.5 | 0.5 |
Echinococcus multilocularis | eukaryotic initiation factor 4A | 0.0593 | 0.5 | 0.5 |
Echinococcus multilocularis | eukaryotic initiation factor 4A III | 0.0593 | 0.5 | 0.5 |
Leishmania major | eukaryotic initiation factor 4a, putative | 0.0593 | 0.5 | 0.5 |
Trypanosoma cruzi | Eukaryotic initiation factor 4A-1 | 0.0593 | 0.5 | 0.5 |
Plasmodium falciparum | eukaryotic initiation factor 4A | 0.0593 | 0.5 | 0.5 |
Leishmania major | eukaryotic initiation factor 4a, putative | 0.0593 | 0.5 | 0.5 |
Trichomonas vaginalis | DEAD box ATP-dependent RNA helicase, putative | 0.0593 | 0.5 | 0.5 |
Giardia lamblia | Translation initiation factor eIF-4A, putative | 0.0593 | 0.5 | 0.5 |
Trypanosoma brucei | Eukaryotic initiation factor 4A-1 | 0.0593 | 0.5 | 0.5 |
Onchocerca volvulus | Eukaryotic initiation factor 4A homolog | 0.0593 | 0.5 | 0.5 |
Treponema pallidum | ATP-dependent RNA helicase | 0.0593 | 0.5 | 0.5 |
Trichomonas vaginalis | DEAD box ATP-dependent RNA helicase, putative | 0.0593 | 0.5 | 0.5 |
Schistosoma mansoni | DEAD box ATP-dependent RNA helicase | 0.0593 | 0.5 | 0.5 |
Echinococcus granulosus | eukaryotic initiation factor 4A III | 0.0593 | 0.5 | 0.5 |
Trichomonas vaginalis | DEAD box ATP-dependent RNA helicase, putative | 0.0593 | 0.5 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0593 | 0.5 | 0.5 |
Entamoeba histolytica | DEAD/DEAH box helicase, putative | 0.0593 | 0.5 | 0.5 |
Plasmodium vivax | RNA helicase-1, putative | 0.0593 | 0.5 | 0.5 |
Schistosoma mansoni | DEAD box ATP-dependent RNA helicase | 0.0593 | 0.5 | 0.5 |
Mycobacterium tuberculosis | Probable cold-shock DeaD-box protein A homolog DeaD (ATP-dependent RNA helicase dead homolog) | 0.0593 | 0.5 | 0.5 |
Toxoplasma gondii | eukaryotic initiation factor-4A, putative | 0.0593 | 0.5 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (binding) | = 4.66 uM | Inhibition of TDP2 (unknown origin) using 4-nitrophenyl phenylphosphonate as substrate after 60 mins | ChEMBL. | 23859074 |
IC50 (binding) | > 200 uM | Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay | ChEMBL. | 23859074 |
Imax (binding) | = 75 % | Inhibition of TDP2 (unknown origin) using 4-nitrophenyl phenylphosphonate as substrate after 60 mins | ChEMBL. | 23859074 |
Inhibition (binding) | < 30 % | Inhibition of TDP1 (unknown origin) using double-stranded AP-site containing DNA as substrate at 100 uM after 30 mins by fluorescence assay relative to control | ChEMBL. | 23859074 |
permeability (ADMET) | = 0.41 ucm/s | Permeability across apical to basolateral side in human Caco2 cells | ChEMBL. | 23859074 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.